The global antiserum market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of infectious diseases and rise in demand for immunoglobulins. Antisera are used as an immune response against various types of infections such as bacterial, viral, and parasitic infections. Antibacterial serums are used for treatment against bacterial infections while antiviral serums are used for treatment against viral infections. AntRh serums are used for treatment against Rh incompatibility in pregnant women who have been exposed to Rh-positive blood or tissue cells from their fetus or baby during pregnancy or childbirth.
Antitoxin serum is expected to be the fastest growing type segment in the global antiserum market during the forecast period due to its use in treating botulism poisoning caused by botulinum toxin which can cause paralysis and death if not treated on time with antitoxin serum injections. The laboratory application segment is expected to be the largest segment in terms of revenue generation due to its use in diagnosing various types of diseases such as HIV/AIDS, hepatitis B & C, malaria etc, while clinical application segment will be second largest segment due its use in treating various types of diseases such as rabies, tetanus etc, globally during the forecast period from 2021-2030.
- The global population is increasing, which will lead to an increase in the number of people who are susceptible to infectious diseases.
- The emergence of new infectious diseases will also lead to an increase in demand for antiserum products.
- Antibodies are used as a treatment for many autoimmune disorders, and this will also drive demand for antiserum products.
- Antibodies can be used as a treatment for cancer, and this will also drive demand for antiserum products.
- Antibodies can be used as a treatment for allergies, and this will also drive demand for antiserum products.
Industry Growth Insights published a new data on “Antiserum Market”. The research report is titled “Antiserum Market research by Types (Antitoxin Serum, Antibacterial Serum, Antiviral Serum, Anti-Rh Serum), By Applications (Laboratory, Clinical, Other), By Players/Companies Charles River, SSI Diagnostica, BD, GD Animal Health, Novacyt Group, OriGene Technologies, Bethyl Laboratories, FUJIFILM Wako Pure Chemical Corporation, Thermo Scientific, Bio-Rad”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Antiserum Market Research Report
By Type
Antitoxin Serum, Antibacterial Serum, Antiviral Serum, Anti-Rh Serum
By Application
Laboratory, Clinical, Other
By Companies
Charles River, SSI Diagnostica, BD, GD Animal Health, Novacyt Group, OriGene Technologies, Bethyl Laboratories, FUJIFILM Wako Pure Chemical Corporation, Thermo Scientific, Bio-Rad
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Antiserum Market Report Segments:
The global Antiserum market is segmented on the basis of:
Types
Antitoxin Serum, Antibacterial Serum, Antiviral Serum, Anti-Rh Serum
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, Clinical, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River
- SSI Diagnostica
- BD
- GD Animal Health
- Novacyt Group
- OriGene Technologies
- Bethyl Laboratories
- FUJIFILM Wako Pure Chemical Corporation
- Thermo Scientific
- Bio-Rad
Highlights of The Antiserum Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antitoxin Serum
- Antibacterial Serum
- Antiviral Serum
- Anti-Rh Serum
- By Application:
- Laboratory
- Clinical
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antiserum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antiserum is a serum or immunoglobulin that neutralizes an antigen.
Some of the major companies in the antiserum market are Charles River, SSI Diagnostica, BD, GD Animal Health, Novacyt Group, OriGene Technologies, Bethyl Laboratories, FUJIFILM Wako Pure Chemical Corporation, Thermo Scientific, Bio-Rad.
The antiserum market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Antiserum Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Antiserum Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Antiserum Market - Supply Chain
4.5. Global Antiserum Market Forecast
4.5.1. Antiserum Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Antiserum Market Size (000 Units) and Y-o-Y Growth
4.5.3. Antiserum Market Absolute $ Opportunity
5. Global Antiserum Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Antiserum Market Size and Volume Forecast by Type
5.3.1. Antitoxin Serum
5.3.2. Antibacterial Serum
5.3.3. Antiviral Serum
5.3.4. Anti-Rh Serum
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Antiserum Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Antiserum Market Size and Volume Forecast by Application
6.3.1. Laboratory
6.3.2. Clinical
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Antiserum Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Antiserum Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Antiserum Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Antiserum Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Antiserum Demand Share Forecast, 2019-2026
9. North America Antiserum Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Antiserum Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Antiserum Market Size and Volume Forecast by Application
9.4.1. Laboratory
9.4.2. Clinical
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Antiserum Market Size and Volume Forecast by Type
9.7.1. Antitoxin Serum
9.7.2. Antibacterial Serum
9.7.3. Antiviral Serum
9.7.4. Anti-Rh Serum
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Antiserum Demand Share Forecast, 2019-2026
10. Latin America Antiserum Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Antiserum Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Antiserum Market Size and Volume Forecast by Application
10.4.1. Laboratory
10.4.2. Clinical
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Antiserum Market Size and Volume Forecast by Type
10.7.1. Antitoxin Serum
10.7.2. Antibacterial Serum
10.7.3. Antiviral Serum
10.7.4. Anti-Rh Serum
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Antiserum Demand Share Forecast, 2019-2026
11. Europe Antiserum Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Antiserum Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Antiserum Market Size and Volume Forecast by Application
11.4.1. Laboratory
11.4.2. Clinical
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Antiserum Market Size and Volume Forecast by Type
11.7.1. Antitoxin Serum
11.7.2. Antibacterial Serum
11.7.3. Antiviral Serum
11.7.4. Anti-Rh Serum
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.101. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Antiserum Demand Share, 2019-2026
12. Asia Pacific Antiserum Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Antiserum Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Antiserum Market Size and Volume Forecast by Application
12.4.1. Laboratory
12.4.2. Clinical
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Antiserum Market Size and Volume Forecast by Type
12.7.1. Antitoxin Serum
12.7.2. Antibacterial Serum
12.7.3. Antiviral Serum
12.7.4. Anti-Rh Serum
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Antiserum Demand Share, 2019-2026
13. Middle East & Africa Antiserum Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Antiserum Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Antiserum Market Size and Volume Forecast by Application
13.4.1. Laboratory
13.4.2. Clinical
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Antiserum Market Size and Volume Forecast by Type
13.7.1. Antitoxin Serum
13.7.2. Antibacterial Serum
13.7.3. Antiviral Serum
13.7.4. Anti-Rh Serum
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Antiserum Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Antiserum Market: Market Share Analysis
14.2. Antiserum Distributors and Customers
14.3. Antiserum Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Charles River
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SSI Diagnostica
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GD Animal Health
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novacyt Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. OriGene Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bethyl Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. FUJIFILM Wako Pure Chemical Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bio-Rad
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
